Tech Company Financing Transactions
Orthogon Therapeutics Funding Round
Orthogon Therapeutics closed a $5.2 million funding round on 12/10/2024. Investors included private investors.
Transaction Overview
Company Name
Announced On
12/10/2024
Transaction Type
Venture Equity
Amount
$5,200,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate the development of its first-in-class treatments for managing BK virus reactivation in transplant patients.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
45 Dan Road 126
Canton, MA 02021
USA
Canton, MA 02021
USA
Phone
Website
Email Address
Overview
Orthogon Therapeutics is an Angel backed, pre-clinical stage start up developing a pipeline of therapeutics in a range of disease indications with significant unmet medical need.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ali Munawar
Vice President
Mark Spyvee
Browse more venture capital transactions:
Prev: 12/10/2024: Wald.ai venture capital transaction
Next: 12/10/2024: Gentrace venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs